The Cancer Letter

Inside information on cancer research and drug development

Vol.
25
No.
7
July 26, 2002Jul 26, 2002
Free
DOWNLOAD THE PDF

New Therapeutic Options Enhance Breast Cancer Treatment: ASCO Reports

Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

Study Finds No Link Between Pill And Breast Cancer Risk

Vasectomy Doesn’t Increase Prostate Cancer Risk

Drug Slows Tumor Growth In Metastatic Kidney Cancer

STI-571 Effects Are Lasting Against GI Stromal Tumors

Monoclonal Antibody Improves AML Response To Therapy

Protocols Approved During the Month of June 2002

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account